1-10 of 10
Tim Crook
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tissue Factor Pathway Inhibitor 2 ( TFPI2 ) Is Commonly Methylated in Multiple Myeloma

Eleftheria Hatzimichael, MD, PhD, Aggeliki Dasoula, Valentinos Kounnis, Andreas Katsenos, Tim Crook, Evangelos Briasoulis, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4617.
https://doi.org/10.1182/blood.V120.21.4617.4617
Published: 2012
Journal Articles

Methylation Status of the Collagen Prolyl-3 Hydroxylases (C-P3H) and C-P4H Genes in Multiple Myeloma: P3H2 Is Selectively Methylated

Eleftheria Hatzimichael, Aggeliki Dasoula, Konstantinos Lagos, Georgianna Kartalou, George Dranitsaris, Evangelos Briasoulis, Tim Crook
Journal: Blood
Blood (2011) 118 (21): 4639.
https://doi.org/10.1182/blood.V118.21.4639.4639
Published: 2011
Journal Articles

Epigenetic Inactivation Targets the Arginine Biosynthetic Pathway At Two Levels in Multiple Myeloma

Eleftheria Hatzimichael, Aggeliki Dasoula, Nelofer Syed, Peter Szlosarek, George Dranitsaris, Tim Crook, Evangelos Briasoulis
Journal: Blood
Blood (2011) 118 (21): 4640.
https://doi.org/10.1182/blood.V118.21.4640.4640
Published: 2011
Journal Articles

The Prolyl-3-Hydroxylase Leprecan Like 1 (Leprel1) Is a Selective Target for Epigenetic Silencing In Multiple Myeloma.

Eleftheria Hatzimichael, MD, PhD, Evangelia Xirofotou, Aggeliki Dasoula, Cristiana Lo Nigro, Laura Lattanzio, Marco Merlano, George Dranitsaris, Konstantinos Bourantas, Tim Crook
Journal: Blood
Blood (2010) 116 (21): 3645.
https://doi.org/10.1182/blood.V116.21.3645.3645
Published: 2010
Journal Articles

BIK (Bcl2-Interacting Killer) CpG Methylation Status in Multiple Myeloma Patients: a Potential Predictor of Relapsed/Refractory Disease.

Eleftheria Hatzimichael, Aggeliki Dasoula, George Dranitsaris, Amalia Vassou, Justin Stebbing, Tim Crook, Konstantinos Bourantas
Journal: Blood
Blood (2009) 114 (22): 2397.
https://doi.org/10.1182/blood.V114.22.2397.2397
Published: 2009
Journal Articles

Methylation Status of SMURF2 and Correlation with Clinical Parameters in Patients with Multiple Myeloma

Eleftheria Hatzimichael, Aggeliki Dasoula, Justin Stebbing, George Dranitsaris, Konstantinos Bourantas, Tim Crook
Journal: Blood
Blood (2008) 112 (11): 4472.
https://doi.org/10.1182/blood.V112.11.4472.4472
Published: 2008
Journal Articles

Snk/Plk2 Methylation Is a Frequent Event in Patients with Multiple Myeloma

Eleftheria Hatzimichael, George Dranitsaris, Aggeliki Dasoula, Nelofer Syed, Justin Stebbing, Tim Crook, Konstantinos Bourantas
Journal: Blood
Blood (2008) 112 (11): 4479.
https://doi.org/10.1182/blood.V112.11.4479.4479
Published: 2008
Journal Articles

Epigenetic Profiling Identifies EGLN3 as a Frequent Target for Transcriptional Silencing in Plasma Cell Neoplasias.

Reshma Shah, Eleftheria Hatzimichael, MD, Nelofer Syed, PhD, Konstantinos L. Bourantas, MD, PhD, Tim Crook, MRCP, PhD
Journal: Blood
Blood (2007) 110 (11): 2132.
https://doi.org/10.1182/blood.V110.11.2132.2132
Published: 2007
Journal Articles

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Nelofer Syed, Paul Smith, Alexandra Sullivan, Lindsay C. Spender, Martin Dyer, Lorraine Karran, Jenny O'Nions, Martin Allday, Ingrid Hoffmann, Dorothy Crawford, Beverley Griffin, Paul J. Farrell, Tim Crook
Journal: Blood
Blood (2006) 107 (1): 250–256.
https://doi.org/10.1182/blood-2005-03-1194
Published: 2006
Journal Articles

p53 Abnormalities in B-Cell Prolymphocytic Leukemia

Daniela Lens, Pierre J.J.C. De Schouwer, Rifat A. Hamoudi, Munah Abdul-Rauf, Nahla Farahat, Estella Matutes, Tim Crook, Martin J.S. Dyer, Daniel Catovsky
Journal: Blood
Blood (1997) 89 (6): 2015–2023.
https://doi.org/10.1182/blood.V89.6.2015
Published: 1997